Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α Therapy.
Anita PusztaiAttila HamarÁgnes HorváthKatalin GulyásEdit VéghNóra BodnárGyörgy KerekesMonika CzókolyováSzilvia SzamosiLevente BodokiKatalin HodosiAndrea DomjánGábor NagyIbolya SzöllősiLuis R LopezEiji MatsuuraZoltán ProhászkaSándor SzántóZoltán NagyYehuda ShoenfeldZoltán SzekaneczGabriella SzűcsPublished in: The Journal of rheumatology (2020)
These biomarkers may be involved in the pathogenesis of atherosclerosis underlying RA/AS. TNF inhibition variably affects the serum levels of oxLDL/β2-GPI, suPAR, and BNP.